Integra LifeSciences Holdings Corporation
Integra LifeSciences Holdings Corporation (Nasdaq: IART) is a global medical technology company that manufactures and sells products for neurosurgery, surgical instrumentation, ear, nose and throat procedures, wound care, and tissue reconstruction. Its Codman Specialty Surgical segment, about 70% of revenue, supplies… From the company’s description.
Over the twelve months to Sep 30, 2026, Integra LifeSciences Holdings Corporation reported revenue of $1.66B, up 0.8% from a year earlier, and net income of $13.01M. Its operating margin was 4.4%, and operations generated $140.40M in cash. In fiscal 2025, it reported revenue of $1.64B, up 1.5% from fiscal 2024, and a net loss of $516.47M.
Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure. is shown separately from the annual figures.
What Integra LifeSciences Holdings Corporation does
In the company’s own words
Integra LifeSciences Holdings Corporation (Nasdaq: IART) is a global medical technology company that manufactures and sells products for neurosurgery, surgical instrumentation, ear, nose and throat procedures, wound care, and tissue reconstruction. Its Codman Specialty Surgical segment, about 70% of revenue, supplies technologies and instruments for neurosurgery, neurocritical care, ENT, and specialty and general surgery. Products include CUSA ultrasonic surgical aspirators, intracranial pressure monitors, dural grafts and sealants, hydrocephalus devices, surgical instruments, and ENT navigation and balloon dilation systems. Its Tissue Technologies segment, about 30% of revenue, develops regenerative tissue products for wound reconstruction and care, soft-tissue repair, and private-label customers. Its portfolio includes Integra Skin, PriMatrix, MicroMatrix, MediHoney, SurgiMend, and DuraSorb. The company sells globally through direct representatives and independent distributors to hospitals, health networks, surgical centers, clinicians, and other healthcare providers; it also supplies technologies and materials to medical technology companies for private-label distribution.
Company details
- Sector
- Health Care
- Industry (SIC)
- Surgical & Medical Instruments
- Headquarters
- PRINCETON, NJ
- Fiscal year end
- December
- CIK
- 917520
- SIC
- 3841
Financial performance, year by year
Fiscal 2011–2025 · USDThe full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.
Who owns Integra LifeSciences Holdings Corporation — and what changed
Funds as of 2026Q2 · superinvestors as of 2026-06-30
Largest fund holders · Integra LifeSciences Holdings Corporation’s weight in each
Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.
Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.
Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.
Recent filings
All filings →Each filing opens into its own statements and disclosures here.
Put this business in context.
Compare this company with peers, find it in your funds and follow its financial history with your connected AI:
- “How do Integra LifeSciences Holdings Corporation and its peers compare on margins and cash generation over ten years?”
- “Where did five years of Integra LifeSciences Holdings Corporation's earnings go — cash, debt, buybacks, reinvestment?”
- “What changed in Integra LifeSciences Holdings Corporation's last four quarterly filings that the numbers alone won't show?”